Issue link: https://viewer.e-digitaledition.com/i/751011
PinnacleHealth CardioVascular Institute Furthers Research into Innovative Cardiovascular Devices BY MICHAEL A. YOUNG, PRESIDENT & CEO, PINNACLEHEALTH SYSTEM FOLLOWING THE TRIAL a nd the FDA's approva l for com mercia l use in Ju ly 2016, P i n n a cleHea lt h wa s t he f i r s t hea lth system to implant the innovative dev ice i n a patient i n Pen nsylva n ia , a nd it was the f irst in the United States t o t reat a hea r t at t a ck pat ient w it h Absorb BVS. Absorb BVS is made of polylactide, a natura l ly dissolvable materia l that is commonly used in medica l impla nts such as dissolving sutures. It works like other dr ug-eluting stents by opening a clogged vessel a nd restor ing blood f low to the hea r t. Unlike a perma nent meta llic impla nt, however, the Absorb BVS then dissolves into the blood vessel, leav i ng beh i nd a treated vessel t hat m ay resu me more n at u ra l f u nc t ion a nd movement because it is free of a meta llic impla nt. "A s a physicia n , it i s i nv i gorat i n g to be a pa r t of clinica l resea rch t hat p o s it ive ly i mpa c t s ou r pa t ient s i n Centra l Pennsylva nia ," says Wi llia m Bachinsky, MD, FACC, FSCAI, Director o f C a r d i o v a s c u l a r R e s e a r c h a n d t he c a rd i a c c at het er i z at ion l a bs at PinnacleHea lth. " By pa r ticipating in clinica l tria ls at PinnacleHea lth, we bring cut ting-edge technolog y to the reg ion yea rs before FDA approva l for commercia l use." The A BSOR B III clinica l tria l wa s designed to eva luate potentia l benef its of the Absorb BVS, made by hea lthca re From left: Jennifer Everhart, RN-BC; William Bachinsky, MD, FACC, FSCAI; Bernadette Eisenberger, BSN, RN, RCIS; Larry Bortner, RCIS; and Nicole°Neidig, RN, BSN, RCIS IN MAY OF 2013, PINNACLEHE ALTH EMBARKED ON AN E XCITING JOURNE Y IN CARING FOR PATIENTS WITH BLOCKED HE ART ARTERIES WHEN IT BEGAN PARTICIPATING IN A THREE¢YE AR CLINICAL TRIAL FOR THE FIRST¢OF¢ITS¢KIND DRUG¢ELUTING ABSORB BIORESORBABLE VA SCUL AR SCAFFOLD šBVS›. 1 4 1 4❱❱❱❱❱ C L I N I C A L T R I A L S

